A screenshot of a webpage from the website OFIRMEV. The webpage is titled "Less pain. Less opioids. From the start."
On the right side of the page there is a picture of a vial of the medication. The vial is white with a blue label and a blue cap. The label has the brand name "OFIRMEV" written in bold black letters at the top. Below the label there are several bullet points that explain the medication's purpose and benefits.
The first bullet point explains that the medication can be used to reduce pain reduce inflammation and improve overall health. The second bullet point mentions that it can be administered in a clinical setting. The third bullet point discusses the potential risks and benefits of using the medication such as increased risk of inflammation decreased risk of heart disease and increased heart health.
- There is also a warning label at the bottom of the image that reads "Warning: Risk of Medication Errors and Hepatitis."
Overall the webpage provides information about the medication and its potential risks associated with it.
Description 
Type
Category
-
Date
2015
Collection
We encourage you to view the image in the context of its source document(s) and cite the source(s) when using these images. However, to cite just this image alone, click the “Cite This Image” button and then paste the copied text.
![A flowchart that shows the steps involved in the treatment of pediatric patients with bilateral otitis media with effusion undergoing TTP surgery. The flowchart is divided into six phases each with a different color and label.<br /><br />The first phase is labeled "Preliminary Phase 1" and is followed by "Phase 2" and "Phase 3" [etc.]](https://oida-resources-images.azureedge.net/public/full/312d2522-d393-4c78-bc97-eecabd457887.JPG)
